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Total thyroidectomy (TT) has emerged as a surgical option in the surgical treatment of patients with
multinodular goiter. TT carries potential risk to all parathyroid glands and both recurrent laryngeal nerve.
The aims of this study are to evaluate the difference between serum calcium levels before and after total
and near total thyroidectomy and to compare the rate of postoperative hypocalcemia according to
surgical procedures.
This prospective study included 143 consecutive patients undergoing surgical therapy for non-toxic
multinodular goiter. Patients were randomly assigned to surgical procedures. Patients in group 1 (n¼ 75)
performed TT, and patients in group 2 (n¼ 68) performed near total thyroidectomy (NTT). The difference
between serum calcium levels and percentage decrease in serum calcium levels before and after
thyroidectomy were calculated.
TT had a 33-fold (OR: 33.1; 95% CI: 7.5–145.02) increased risk for hypocalcemia. Moreover, TT had a
8-fold (OR: 8.09; 95% CI: 3–21.4) and a 27-fold (OR: 27.9; 95% CI: 3.5–219.6) higher risk than NTT for
moderate and severe percentage decreases in serum calcium level, respectively.
NTT can offer an advantage over TT in terms of postoperative hypocalcemia in the patients with benign
multinodular goiter.
 2008 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Multinodular goiter (MNG) is the most common indication for
thyroidectomy in endemic iodine-deﬁcient regions.1,2 The goal of
surgical treatment in thyroid disease should be to eliminate the
disease with low complication rates and to minimize reoperation
for incidental thyroid carcinoma in MNG.1–3 In the recent years,
total thyroidectomy (TT) has emerged as a surgical option in the
surgical treatment of patients with MNG. However, there is
considerable debate about the most appropriate surgical option for
MNG.4,5
TT carries potential risk to all parathyroid glands and both
recurrent laryngeal nerve. Postoperative hypocalcemia is
a common complication following total thyroidectomy. Biochem-
ical hypocalcemia has been reported in as many as 50% of patientsrch Hospital, General Surgery
x: þ90 232 2431530.
ciates Ltd. Published by Elsevier Ltand hypocalcemia is the principal factor that determines length of
hospital stay after thyroid surgery.5–9
Familiarity with the anatomy of parathyroid glands and their
blood supply is necessary to prevent injury or devascularization
of the parathyroid gland(s). Improvements in surgical tech-
nique cannot eliminate the risk of hypocalcemia; therefore,
hypocalcemia occur even in the hands of the more experienced
thyroid surgeons.6–8 Although the cause of postoperative
hypocalcemia is multifactorial, surgical trauma of parathyroid
gland(s) is one of the most frequent causes.10,11 The difference
between serum calcium levels before and after thyroidectomy
could occur during the TT, however, how many patients
suffered from developing hypocalcemia due to this difference is
not known.
The aims of this prospective clinical study are: (1) to eval-
uate the difference between serum calcium levels before and
after total and near total thyroidectomy (NTT), and (2) to
compare the rate of postoperative hypocalcemia according to
surgical procedures, and (3) to suggest that NTT might be safer
option to TT in terms of lesser rates of postoperative
hypocalcemia.d. All rights reserved.
Table 1
The comparison of the patients with or without hypocalcemia.
Parameters Patients with
hypocalcemia
(group 1, n¼ 34)
Patients with
normocalcemia
(group 2, n¼ 109)
p
Age (years) 54.5 12 45.8 11 0.001
Gender F/M 5/29 15/94 NS
Preoperative PTH level (pg/dL) 34.7 11 36.7 9 NS
Preoperative Hct level (%) 36.6 36.9 NS
Preoperative Ca level (mg/dL) 9.4 0.3 9.3 0.4 0.06
Postoperative Ca level (mg/dL) 7.4 0.3 8.7 0.5 0.001
Difference between
serum calcium levels
(mg/dL)
2 0.4 0.5 0.4 0.001
The ratio of total
thyroidectomy (%)
97.1 38.5 0.001
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2.1. Patients
This prospective study included 143 consecutive patients
undergoing surgical therapy for non-toxic multinodular goiter at
the Department of General Surgery, Ataturk Training and Research
Hospital, between May 2007 and June 2008. Patients were
randomly assigned to surgical procedures. Patients in group 1
(n¼ 75) performed total thyroidectomy, and patients in group 2
(n¼ 68) performed near total thyroidectomy. Patients having
hyperthyroidism, substernal goiter or a previous thyroid or neck
operations, and concomitant parathyroid disease as well as those
who refused to participate in this study were excluded from the
present study.
None of the patients had signs or symptoms indicating meta-
bolic bone disease and none of the patients were on medication
known to affect serum calcium metabolism. The study plan was
reviewed and approved by our institutional ethical committee, and
informed consent was obtained from all patients.
The main indications for surgery were large goiter with
compressive effect to all of the patients. All thyroid procedures
were performed by experienced surgeons using the conventional
clamp-and-tie technique. Vessel sealing systems including
ultrasonic dissectors, electrothermal bipolar vessel sealers, and
titanium clips were not used. Total thyroidectomy was performed
by extracapsular dissection. Near total thyroidectomy was per-
formed by the capsular dissection method, and less than 1 g of
remnant tissue was left around the Berry ligament. For the
remnant tissue, we estimated that 1 cm3 equaled 1 g. Recurrent
laryngeal nerves were carefully identiﬁed and dissected. All
parathyroid glands identiﬁed and preserved with meticulous
dissection for their blood supply. Serum hematocrit (Hct),
calcium (Ca) and PTH levels were determined the day before
surgery and serum calcium was measured 24 h postoperatively.
Serum calcium concentration was adjusted for serum albumin.
The difference between serum calcium levels and percent
decrease in serum calcium levels before and after thyroidectomy
was calculated.
Hypocalcemia was deﬁned as a serum calcium level< 8 mg/dl
after operation. The presence of clinical symptom or signs of
hypocalcemia were noted. Persistent hypoparathyroidism was
deﬁned as serum parathyroid hormone levels below 10 pg/ml in
patients requiring treatment for more than 3 months to maintain
normocalcemia.
2.2. Biochemical analysis
Serum calcium levels were determined by auto-analyzer (Cobas
Integra 800, Roche Diagnostics, Basel, Switzerland). Serum PTH and
surgical site irrigation ﬂuid PTH levels were determined by
immunoradiometric assay using commercially available kitsdthe
PTH-120 min-IRMA kit (BioSource Europe S.A., Nivelles, Belgium).
Normal ranges of biochemical parameters were 8.5–10.5 mg/dL for
serum calcium and 10–65 pg/mL for serum PTH concentrations.
2.3. Statistics
Data were analyzed using SPSS 11.0 for Windows. Results were
expressed as means SD. Comparisons of data were performed by
Mann–Whitney U, Wilcoxon, Student’s-t, paired t-test, ANOVA and
chi-squared tests. Correlation analysis of continuous variables was
performed using Spearman’s rank test. Results were considered
statistically signiﬁcant when the two-tailed p-value was less than
0.05.3. Results
3.1. Patients
The mean (SD) age was 47.912 years (range, 20–77 years) for
143 patients. The female to male ratio was 6.1:1 (n¼ 123 and 20,
respectively). The mean (SD) for preoperative serum calcium and
PTH levels, postoperative serum calcium, the difference between
serum calcium levels, percentage decrease in serum calcium levels,
and thyroid volume were 9.3 0.4 mg/dL, 37.713 pg/dL,
8.4 0.6 mg/dL, 0.9 0.7 mg/dL, 9.47.8%, and 72 24 mg,
respectively. The postoperative serum calcium level was lower than
the preoperative serum calcium level (8.4 0.6 mg/dL vs.
9.3 0.4 mg/dL, p< 0.001). Therewas not any signiﬁcant difference
between preoperative and postoperative Hct levels (36.8% vs.
37.9%) (p> 0.05).
There was no operative mortality. The incidence of transient
vocal cord paralysis was 3.5% (5/143). Persistent vocal cord paral-
ysis and hypoparathyroidismwere not encountered in our series. In
34 (23.7%) patients, serum calcium level was found to be less than
8 mg/dL at the postoperative 24 h.
3.2. Evaluation of the patients with or without hypocalcemia
In the patients with hypocalcemia, age was found to be
signiﬁcantly higher when compared to the patients with normo-
calcemia (p¼ 0.001). There were not any signiﬁcant difference
between preoperative serum calcium and PTH levels, post-
operative Hct level, and thyroid volume (p> 0.05). The post-
operative serum calcium level in the patients with hypocalcemia
was signiﬁcantly lower than in the patients with normocalcemia
(p¼ 0.001). The ratio of TT in the patients with hypocalcemia was
signiﬁcantly higher than in the patients with normocalcemia
(p¼ 0.001) (Table 1). Of 34 patients, 20 (58.8%) developed symp-
tomatic hypocalcemia and 14 (41.2%) developed asymptomatic
hypocalcemia. Hospital stay in the patients with hypocalcemia
(4.11.3 days, range 2–7 days) was signiﬁcantly longer than in the
patients with normocalcemia (1.2 0.3 days, range 1–2 days)
(p¼ 0.001).
3.3. Evaluation of the patients according to the percentage
decrease in serum calcium levels
One hundred forty-three patients were divided according to
percentage decrease in serum calcium levels before and after
thyroidectomy. Patients (n¼ 93) have percent decrease in serum
calcium levels 0–10% (minimal percent decrease in serum calcium
H.R. Unalp et al. / International Journal of Surgery 7 (2009) 120–125122level), patients (n¼ 32) have percent decrease in serum calcium
levels 11–20% (moderate percent decrease in serum calcium level),
and patients (n¼ 18) have percent decrease in serum calcium levels
>21% (severe percent decrease in serum calcium level). The mean
minimal, moderate and severe percent decrease in serum calcium
levels were 4.4 2.9%, 15 2.6% and 25 2.9%, respectively.
Mean age in the patients with moderate (5211 years) and
severe (53.413 years) percent decrease in serum calcium level
were signiﬁcantly higher than in the patients with minimal
(45.311 years) percent decrease in serum calcium level
(p< 0.05). There were not any signiﬁcant difference between
preoperative serum calcium and PTH levels of the patients minimal
(9.2 0.3 mg/dL and 35 9 pg/dL), moderate (9.4 0.3 mg/dL and
347 pg/dL) and severe (9.5 0.3 mg/dL and 35 8 pg/dL)
percent decrease in serum calcium levels (p> 0.05).
The mean for postoperative serum calcium levels in the patients
with moderate (8 0.3 mg/dL) and severe (7.2 0.2 mg/dL)
percent decrease in serum calcium level were signiﬁcantly lower
than in the patients with minimal (8.8 0.3 mg/dL) percent
decrease in serum calcium level (p< 0.001). The mean for differ-
ence between serum calcium levels in the patients with moderate
(1.4 0.2 mg/dL) and severe (2.4 0.3 mg/dL) percent decrease in
serum calcium level were signiﬁcantly higher than in the patients
with minimal (0.4 2.9 mg/dL) percent decrease in serum calcium
level (p< 0.001) (Fig. 1).
The ratios of hypocalcemia and TT in the patients withmoderate
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Fig. 1. Comparison of the patients according to the percent change in serum calcium leve
calcium levels before and after thyroidectomy; and (D) the percent decrease in serum calcserum calcium level were signiﬁcantly higher than in the patients
with minimal (0% and 30.1%) percent decrease in serum calcium
level (p< 0.05) (Fig. 2).3.4. Evaluation of the patients according to the surgical procedure
In the group 1, age was found to be signiﬁcantly higher when
compared to the group 2 (p¼ 0.001). Therewere not any signiﬁcant
difference between preoperative serum calcium and PTH levels of
the group 1 and 2 (p> 0.05). The postoperative serum calcium level
in group 1 was signiﬁcantly lower than in group 2 (p¼ 0.001). The
difference between serum calcium levels and percent decrease in
serum calcium levels before and after thyroidectomy in group 1
was signiﬁcantly higher than in group 2 (p¼ 0.001). The ratios of
hypocalcemiawere 44% in group 1 and 1.5% in group 2. The ratios of
hypocalcemia in group 1 was signiﬁcantly higher than in group 2
(p¼ 0.001). Moderate and severe percent decrease in serum
calcium levels in group 1 was signiﬁcantly higher than in group 2,
whereas minimal percent decrease in serum calcium levels in
group 1 was signiﬁcantly lower than in group 2 (p¼ 0.001)
(Table 2).
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There was a negative correlation between postoperative serum
calcium level and age (r¼0.420, p¼ 0.0001) and total thyroid-
ectomy (r¼0.464, p¼ 0.0001). There was a positive correlation
between TT and the difference between serum calcium level
(r¼ 0.483, p¼ 0.0001) and percent decrease in serum calcium level
(r¼0.629, p¼ 0.0001) (Fig. 3).
3.6. Histopathological evaluation
Papillary carcinoma was detected in 16 patients (11%), of whom
13 (81%) had papillary microcarcinoma (<1 cm). The patients wereTable 2
The comparison of the patients according to the surgical procedure.
Parameters Patients performed
TT (n¼ 75)
Patients performed
NTT (n¼ 68)
p
Age (years) 50.2 11 45.3 12 0.02
Gender F/M 11/64 9/59 NS
Preoperative Ca level (mg/dL) 9.4 0.3 9.4 0.7 NS
Postoperative Ca level (mg/dL) 8.1 0.7 8.7 0.4 0.001
Difference between serum
calcium levels (mg/dL)
1.3 0.7 0.4 0.4 0.001
Decrease in serum calcium
levels (%)
13.8 7.7 4.5 4.4 0.001
Minimal decrease in serum
calcium levels (%)
37.3 95.6 0.001
Moderate decrease in serum
calcium levels (%)
40 2.9 0.001
Severe decrease in serum
calcium levels (%)
22.7 1.5 0.001
The ratio of hypocalcemia (%) 44 1.5 0.001classiﬁed as low risk group according to their MACIS scores. None of
the patients underwent completion thyroidectomy. Incidentally
excised parathyroid glands have been reported in 5 patients. None
of these patients developed hypocalcemia.
4. Discussion
We investigated if NTT has a safer alternative in terms of lesser
rates of postoperative hypocalcemia and we found that TT was
signiﬁcantly associated with postoperative hypocalcemia. There
was a positive correlation between TT and the percent decrease in
serum calcium level. As the moderate and severe percent decrease
in serum calcium levels increase, the rate of hypocalcemia
increases. Moderate and severe percent decrease in serum calcium
levels in the patients performed TT was signiﬁcantly higher than in
the patients performed NTT. TT had a 33-fold increased risk for
hypocalcemia. Moreover, TT had a 8-fold and a 27-fold higher risk
than NTT for moderate and severe percent decreases in serum
calcium level, respectively.
Although the morbidity of thyroid surgery has decreased over
the past century, postoperative hypocalcemia is the most frequent
complication after TT and continue to challenge even the experi-
enced surgeon. The incidence of hypocalcemia varied from 1.6% to
above 50%.10–12 In the several studies, type of thyroid disease (i.e.,
malignant vs. benign) or the extent of thyroid surgery, hyperthy-
roidism, retrosternal goiter, concomitant neck dissection, comple-
tion thyroidectomy/reoperations, inadvertent removal of
parathyroid glands, the number of functioning glands left behind,
extent of surgery, the experience of the surgeon, have been corre-
lated with an increased risk for unintentional para-
thyroidectomy.13–19
Improvements in surgical technique cannot eliminate the
postoperative hypocalcemia. In the recent years, there has been
a great deal of interest in identifying perioperative factors that
could be predicting the development of hypocalcemia after
thyroidectomy.20–22 Intraoperative or postoperative serum PTH
measurements have been demonstrated to be useful in the iden-
tiﬁcation of patients who are at risk for hypocalcemia.20–24 Its
clinical usefulness may also be cost effective by reducing post-
operative hospital stay and the need for expensive postoperative
serum calciummonitoring. In our study, hospitalization period was
longer in patients with hypocalcemia compared to patients with
normocalcemia.
MNG is the commonest endocrine disorder.1,2 Although there are
no strong recommendations of the appropriate surgical procedure
for MNG, TT has emerged as a surgical option to treat patients with
MNG especially in endemic iodine-deﬁcient regions.4–6 TT for MNG
provides the advantages of eliminating the risk of recurrence, and of
being an adequate surgical procedure for an incidental micro-
carcinoma. Many microcarcinomas may remain occult and are
diagnosed as an incidental ﬁnding during surgery for benign thyroid
disorders. However, some microcarcinomas may have a negative
outcome, including distant metastasis and patient death.25–28
In the recent studies showed that reoperationwas not necessary
in MNG patients treated with NTT, whereas who is treated with
subtotal thyroidectomy (STT) had to undergo reoperation for
completion.29 In our study, the incidence of incidental papillary
carcinoma was 9.2% in patients treated NTT. These patients were
scheduled for follow-up only and were not performed completion
thyroidectomy. NTT can be recommended in MNG to eliminate the
need for completion thyroidectomy in case of a ﬁnal diagnosis of
thyroid cancer.
The rate of recurrence is high after subtotal resections for MNG
in long-term follow-up, despite postoperative thyroid hormone
supplementation. A considerable number of patients undergoing
Fig. 3. Correlations between postoperative serum calcium level and age (A), TT and postoperative serum calcium level (B), TT and the difference between serum calcium level (C), TT
and the percent decrease in serum calcium level and (D).
H.R. Unalp et al. / International Journal of Surgery 7 (2009) 120–125124primary treatment with subtotal resection need reoperation for
recurrence, which has a higher rate of complication compared with
the primary procedures. Studies comparing STT and TT suggest that
STT is associated with signiﬁcant recurrence of goiters compared to
TT.30–33 No study was found that compared the recurrence rates of
MNG after the NTT.
Most studies suggest that the incidence of transient hypocal-
cemia is higher after TT than after STT, but the incidence of tran-
sient nerve palsy is not signiﬁcantly different between the two
procedures.32–34 However, there are few studies that most of them
were carried out retrospectively whereas only one of those was
prospective study composed of comparison of the postoperative
complications of TT and NTT.35–38 Results of these studies indicatethat TT is a safe procedure in the hands of expert surgeons, and it is
associated with acceptably low rates of permanent complications.
However, these studies suggest that the incidence of transient
hypocalcemia is higher after TT than after NTT.
In our study, 62.7% of the patients who underwent TT were
found to bewith decreased level of calcium that was over 10%while
this decrement level was 4.4% of the patients who underwent NTT.
The rate of the hypocalcemia was found to be in 44% of the patients
underwent TT and in 1.5% of the patients underwent NTT. Ninety-
ﬁve percent of the patients underwent NTT was found to be with
decreased level of calciumwas less than 10%. Of these patients who
underwent NTT were not detected hypocalcemia that could be due
to hemodilution.
H.R. Unalp et al. / International Journal of Surgery 7 (2009) 120–125 125In conclusion, NTT is provided similar results to TT by providing
adequate treatment of incidental thyroid carcinoma and NTTcan be
offer advantage over TT in terms of postoperative hypocalcemia in
the patients with benign MNG.Conﬂicts of interest
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